180 related articles for article (PubMed ID: 23891099)
1. Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: normal tissue complication probability modeling with latent time correction.
Rønjom MF; Brink C; Bentzen SM; Hegedüs L; Overgaard J; Johansen J
Radiother Oncol; 2013 Nov; 109(2):317-22. PubMed ID: 23891099
[TBL] [Abstract][Full Text] [Related]
2. External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohort.
Rønjom MF; Brink C; Bentzen SM; Hegedüs L; Overgaard J; Petersen JB; Primdahl H; Johansen J
Acta Oncol; 2015; 54(9):1301-9. PubMed ID: 26248025
[TBL] [Abstract][Full Text] [Related]
3. Variation of normal tissue complication probability (NTCP) estimates of radiation-induced hypothyroidism in relation to changes in delineation of the thyroid gland.
Rønjom MF; Brink C; Lorenzen EL; Hegedüs L; Johansen J
Acta Oncol; 2015; 54(8):1188-94. PubMed ID: 25629441
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced hypothyroidism after treatment of head and neck cancer.
Feen Rønjom M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
[TBL] [Abstract][Full Text] [Related]
5. Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.
Kinclová I; Hajtmanová E; Matula P; Balentová S; Muríň P; Ďuroška M; Kozlíková K
Strahlenther Onkol; 2020 Jun; 196(6):561-568. PubMed ID: 32016495
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapeutic factors affecting the incidence of developing hypothyroidism after radiotherapy for head and neck squamous cell cancer.
El-Shebiney M; El-Mashad N; El-Mashad W; El-Ebiary AA; Kotkat AE
J Egypt Natl Canc Inst; 2018 Mar; 30(1):33-38. PubMed ID: 29428369
[TBL] [Abstract][Full Text] [Related]
7. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy.
Bakhshandeh M; Hashemi B; Mahdavi SR; Nikoofar A; Vasheghani M; Kazemnejad A
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):514-21. PubMed ID: 22583606
[TBL] [Abstract][Full Text] [Related]
8. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
[TBL] [Abstract][Full Text] [Related]
9. A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model.
Boomsma MJ; Bijl HP; Christianen ME; Beetz I; Chouvalova O; Steenbakkers RJ; van der Laan BF; Wolffenbuttel BH; Oosting SF; Schilstra C; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e351-6. PubMed ID: 22717243
[TBL] [Abstract][Full Text] [Related]
10. Thyroid dysfunction in patients treated with radiotherapy for neck.
Koc M; Capoglu I
Am J Clin Oncol; 2009 Apr; 32(2):150-3. PubMed ID: 19307948
[TBL] [Abstract][Full Text] [Related]
11. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
12. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis.
Cella L; Liuzzi R; Conson M; D'Avino V; Salvatore M; Pacelli R
Radiat Oncol; 2012 Dec; 7():224. PubMed ID: 23270411
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function should be monitored following radiotherapy to the low neck.
Garcia-Serra A; Amdur RJ; Morris CG; Mazzaferri E; Mendenhall WM
Am J Clin Oncol; 2005 Jun; 28(3):255-8. PubMed ID: 15923797
[TBL] [Abstract][Full Text] [Related]
14. Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation.
Ling S; Bhatt AD; Brown NV; Nguyen P; Sipos JA; Chakravarti A; Rong Y
Head Neck; 2017 Mar; 39(3):548-554. PubMed ID: 27905164
[TBL] [Abstract][Full Text] [Related]
15. Functional and biochemical changes in the thyroid gland following exposure to therapeutic doses of external beam radiotherapy in the head-and-neck cancer patients.
Randhawa AS; Yadav HP; Banipal RPS; Goyal G; Garg P; Marcus S
J Cancer Res Ther; 2021; 17(4):1025-1030. PubMed ID: 34528559
[TBL] [Abstract][Full Text] [Related]
16. Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients.
Prpic M; Kruljac I; Kust D; Suton P; Purgar N; Bilos LK; Gregov M; Mrcela I; Franceschi M; Djakovic N; Frobe A
Radiol Oncol; 2019 Nov; 53(4):488-496. PubMed ID: 31747379
[TBL] [Abstract][Full Text] [Related]
17. Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy.
Norris AA; Amdur RJ; Morris CG; Mendenhall WM
Am J Clin Oncol; 2006 Oct; 29(5):442-5. PubMed ID: 17023776
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
19. The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy.
Bitz HC; Sachpazidis I; Zou J; Schnell D; Baltas D; Grosu AL; Nicolay NH; Rühle A
Radiat Oncol; 2024 Apr; 19(1):53. PubMed ID: 38689338
[TBL] [Abstract][Full Text] [Related]
20. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma.
Cella L; Conson M; Caterino M; De Rosa N; Liuzzi R; Picardi M; Grimaldi F; Solla R; Farella A; Salvatore M; Pacelli R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1802-8. PubMed ID: 21514076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
